The Nanoplasty™ MIS System is designed to deliver a reproducible 3D correction of the bunion deformity through a cosmetically appealing, hidden incision on the side of the foot and help patients get ...

The device provides nightly relief & correction, which is a great way ... Can bunion correctors straighten a bunion without surgery? Bunion correctors can help slow down the progression of bunions ...

Concepts announced the limited market release of the Nanoplasty 3D Minimally Invasive, MIS, Bunion Correction System and ...

A relatively new form of bunion surgery called Lapiplasty 3D Bunion Correction was cleared by the FDA in 2016. The manufacturer of the Lapiplasty 3D technology — Treace Medical Concepts ...

Here are seven female surgeons who provide care for major sports teams: Nancy Gritter, MD, is a North Carolina-based internal medicine physician who has been the Panthers' lead physician since 2018.

Podiatrists don’t tend to operate on bunions just for cosmetic reasons, but bunion correction surgery is the go-to treatment ...

“Treace Medical was the first company to develop, patent, and introduce an instrumented 3D bunion correction system ... a standard of care in bunion surgery over the past ten years,” said ...

Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023 Third quarter 2024 net loss was ($15.4) million compared to ($17.5) million for same period in 2023. Adjusted ...

With 3 analyst ratings, Treace Medical Concepts has a consensus rating of Neutral. The average one-year price target is $6.83, indicating a potential 42.89% upside.

Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of ...

Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System – a combination of instruments, implants, and surgical methods designed to surgically correct all three ...

“Today’s action is consistent with what we stated publicly earlier this year, namely that our strategy all along has been to assert and enforce our IP rights,” Mr. Treace said. “We also continue to ...